Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Gilbert

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of the National Medical Association|July 1, 1986
The health insurance plight of patients with sickle cell diseaseS K Gilbert
International Journal of Radiation Biology|July 15, 2017
Ionizing radiation induces EphA2 S897 phosphorylation in a MEK/ERK/RSK-dependent mannerPaul R Graves, Shaun U Din, Mark Ashamalla, et al.
Journal of Proteome Research|December 13, 2018
Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell LymphomaMarissa L Cann, Laura E Herring, Lauren L Haar, et al.
Plos One|May 19, 2017
BIRC6 mediates imatinib resistance independently of Mcl-1Denis O Okumu, Michael P East, Merlin Levine, et al.
The Journal of Biological Chemistry|January 4, 2020
Mass spectrometry-based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cellsIan M McDonald, Gavin D Grant, Michael P East, et al.
Molecular & Cellular Proteomics : MCP|February 27, 2017
Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) AntiviralsKyle C Arend, Erik M Lenarcic, Heather A Vincent, et al.
Science Advances|October 26, 2022
Cytomegalovirus US28 regulates cellular EphA2 to maintain viral latencyAmanda B Wass, Benjamin A Krishna, Laura E Herring, et al.
Cancer Research Communications|November 17, 2022
Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial HomeostasisYoshimi Endo Greer, Lidia Hernandez, Emily M J Fennell, et al.
Nature Immunology|January 8, 2025
A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cellsFeifei Song, Ourania Tsahouridis, Simone Stucchi, et al.
Neuro-Oncology|July 9, 2018
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningiomaSteven P Angus, Janet L Oblinger, Timothy J Stuhlmiller, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of the National Medical Association|July 1, 1986
The health insurance plight of patients with sickle cell diseaseS K Gilbert
International Journal of Radiation Biology|July 15, 2017
Ionizing radiation induces EphA2 S897 phosphorylation in a MEK/ERK/RSK-dependent mannerPaul R Graves, Shaun U Din, Mark Ashamalla, et al.
Journal of Proteome Research|December 13, 2018
Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell LymphomaMarissa L Cann, Laura E Herring, Lauren L Haar, et al.
Plos One|May 19, 2017
BIRC6 mediates imatinib resistance independently of Mcl-1Denis O Okumu, Michael P East, Merlin Levine, et al.
The Journal of Biological Chemistry|January 4, 2020
Mass spectrometry-based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cellsIan M McDonald, Gavin D Grant, Michael P East, et al.
Molecular & Cellular Proteomics : MCP|February 27, 2017
Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) AntiviralsKyle C Arend, Erik M Lenarcic, Heather A Vincent, et al.
Science Advances|October 26, 2022
Cytomegalovirus US28 regulates cellular EphA2 to maintain viral latencyAmanda B Wass, Benjamin A Krishna, Laura E Herring, et al.
Cancer Research Communications|November 17, 2022
Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial HomeostasisYoshimi Endo Greer, Lidia Hernandez, Emily M J Fennell, et al.
Nature Immunology|January 8, 2025
A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cellsFeifei Song, Ourania Tsahouridis, Simone Stucchi, et al.
Neuro-Oncology|July 9, 2018
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningiomaSteven P Angus, Janet L Oblinger, Timothy J Stuhlmiller, et al.
Pageof 2